Display options
Cite
Barron CVM, Heenan HF, Thompson H, et al. Detecting dysglycaemia in compensated liver cirrhosis: Comparison of oral glucose tolerance test and glycated haemoglobin, with continuous glucose monitoring. Diabet Med. 2021;e14778doi: 10.1111/dme.14778.
Barron, C. V. M., Heenan, H. F., Thompson, H., Chan, H., Ngu, J., & Lunt, H. (2021). Detecting dysglycaemia in compensated liver cirrhosis: Comparison of oral glucose tolerance test and glycated haemoglobin, with continuous glucose monitoring. Diabetic medicine : a journal of the British Diabetic Association, e14778. https://doi.org/10.1111/dme.14778
Barron, Cicely V M, et al. "Detecting dysglycaemia in compensated liver cirrhosis: Comparison of oral glucose tolerance test and glycated haemoglobin, with continuous glucose monitoring." Diabetic medicine : a journal of the British Diabetic Association vol. (2021): e14778. doi: https://doi.org/10.1111/dme.14778
Barron CVM, Heenan HF, Thompson H, Chan H, Ngu J, Lunt H. Detecting dysglycaemia in compensated liver cirrhosis: Comparison of oral glucose tolerance test and glycated haemoglobin, with continuous glucose monitoring. Diabet Med. 2021 Dec 27;e14778. doi: 10.1111/dme.14778. Epub 2021 Dec 27. PMID: 34957598.
Copy Download .nbib Format: NLM
Share it on

Diabet Med. 2021 Dec 27;e14778. doi: 10.1111/dme.14778. Epub 2021 Dec 27.

Detecting dysglycaemia in compensated liver cirrhosis: Comparison of oral glucose tolerance test and glycated haemoglobin, with continuous glucose monitoring.

Diabetic medicine : a journal of the British Diabetic Association

Cicely V M Barron, Helen F Heenan, Harmony Thompson, Huan Chan, Jeffrey Ngu, Helen Lunt

Affiliations

  1. Department of Medicine, University of Otago Christchurch, Christchurch, New Zealand.
  2. Diabetes Outpatients, Canterbury District Health Board, Christchurch, New Zealand.
  3. Gastroenterology Department, Canterbury District Health Board, Christchurch, New Zealand.

PMID: 34957598 DOI: 10.1111/dme.14778

Abstract

AIMS: Liver cirrhosis increases the risk of developing dysglycaemia (pre-diabetes and diabetes), thus people with cirrhosis should undergo regular screening for dysglycaemia. The utility of screening using the laboratory glycated haemoglobin (HbA

METHODS: Participants ≥18 years with no known diabetes, were recruited from a gastroenterology cirrhosis surveillance register. Study measurements included a 75 g OGTT, laboratory HbA

RESULTS: All 20 participants had compensated cirrhosis. OGTT tended to diagnose more dysglycaemia (N = 7) than did HbA

CONCLUSIONS: In the setting of compensated cirrhosis, the OGTT and HbA

© 2021 Diabetes UK.

Keywords: blood glucose; glucose tolerance test; glycated haemoglobin; haptoglobins; hypoglycaemia; liver cirrhosis; monitoring, ambulatory; pre-diabetic state

References

  1. Garcia-Compean D, Jaquez-Quintana JO, Gonzalez-Gonzalez JA, Maldonado-Garza H. Liver cirrhosis and diabetes: risk factors, pathophysiology, clinical implications and management. World J Gastroenterol. 2009;15(3):280-288. doi:10.3748/wjg.15.280 - PubMed
  2. Marrero JA, Kulik LM, Sirlin CB, et al. Diagnosis, staging, and management of hepatocellular carcinoma: 2018 practice guidance by the American Association for the Study of Liver Diseases. Hepatology. 2018;68(2):723-750. doi:10.1002/hep.29913 - PubMed
  3. Silva TE, Ronsoni MF, Schiavon LL. Challenges in diagnosing and monitoring diabetes in patients with chronic liver diseases. Diabetes Metab Syndr. 2018;12(3):431-440. doi:10.1016/j.dsx.2017.12.013 - PubMed
  4. Nadelson J, Satapathy SK, Nair S. Glycated hemoglobin levels in patients with decompensated cirrhosis. Int J Endocrinol. 2016;2016:8390210. doi:10.1155/2016/8390210 - PubMed
  5. Bergenstal RM, Beck RW, Close KL, et al. Glucose Management Indicator (GMI): a new term for estimating A1C from continuous glucose monitoring. Diabetes Care. 2018;41(11):2275-2280. doi:10.2337/dc18-1581 - PubMed
  6. World Health Organization. Definition diagnosis and classification of diabetes mellitus and its complications. Diagnosis and classification of diabetes melitus report of a WHO Consultation. Part 1. World Health Organization. - PubMed
  7. Honda F, Hiramatsu A, Hyogo H, et al. Evaluation of glycemic variability in chronic liver disease patients with type 2 diabetes mellitus using continuous glucose monitoring. PLoS One. 2018;13(4):e0195028. doi:10.1371/journal.pone.0195028 - PubMed
  8. Sequiera IR, Poppitt SD. HbA1c as a marker of prediabetes: a reliable screening tool or not? Insights Nutr Metabol. 2017;1(1):21-29 (Review). - PubMed
  9. Bergman M, Abdul-Ghani M, DeFronzo RA, et al. Review of methods for detecting glycemic disorders. Diabetes Res Clin Pract. 2020;165:108233. doi:10.1016/j.diabres.2020.108233 - PubMed
  10. Nishida T. Diagnosis and clinical implications of diabetes in liver cirrhosis: a focus on the oral glucose tolerance test. J Endocr Soc. 2017;1(7):886-896. doi:10.1210/js.2017-00183 - PubMed

Publication Types

Grant support